EuroCor gets CE mark for TAXCOR
BANGALORE: EuroCor Life Sciences, a wholly owned subsidiary of healthcare equipment maker Opto Circuits (India) Ltd (OCIL), has received CE approval for marketing and sale of drug eluting stents called TAXCOR. "Obtaining this approval allows EuroCor to sell TAXCOR globally, with the exception of the U.S. and Japan. TAXCOR has a current addressable market of at least 40 per cent of the large global market," says Vinod Ramnani, Chairman and Managing Director, OCIL.
Printer friendly page
Send this article to Friends by E-Mail
SOURCE
No comments:
Post a Comment